Essay · 12 April 2026
Difficulty Launching New Products
Organizations often face challenges in launching new products, impacting growth and innovation. Issues arise from unclear processes, slow development cycles, and poor team alignment, leading to missed opportunities. A structured approach to product development and launches enhances speed and success rates, allowing businesses to stay competitive and meet customer needs effectively.
Dr. Maralani

The inability to successfully launch and sustain new offerings often indicates a fundamental disconnect between strategic intent and operational execution. When organizations struggle to bring products to market effectively, the resulting friction manifests as a persistent gap between innovation investment and realized commercial value.
How it shows up
- Management deliberations frequently circle back to the status of the innovation pipeline without reaching actionable resolutions or definitive progress.
- Internal performance indicators regarding new launches trend downward or become increasingly difficult for leadership to interpret or explain.
- Operational results vary significantly across different teams, customer segments, or geographic regions, suggesting a lack of standardized discipline.
- The organization appears to repeat specific failures across multiple initiatives, demonstrating a failure to institutionalize lessons from previous cycles.
What usually sits underneath
Product launch difficulties are rarely isolated incidents; they typically stem from unclear accountability for business outcomes and a lack of defined decision rights. When execution fails to produce the intended results, it often reveals that the organization lacks the necessary routines, data, or incentives to detect and correct deviations early in the lifecycle. Furthermore, these challenges frequently point to a deficit in governance and professional discipline, where the enthusiasm for new ideas supersedes the rigorous management required to ensure those ideas are viable and scalable.
Questions leadership should ask
- What objective evidence suggests that inefficiencies in the product roadmap or pipeline are materially compromising the organization’s overall results?
- Which specific leader is held accountable for the health of the innovation lifecycle, and do they possess the requisite authority to enforce changes?
- Is the current struggle primarily a result of flawed strategy, insufficient internal capability, an inadequate operating model, or external market pressures?
- Are senior management decisions regarding the portfolio being blocked or repeatedly escalated due to a lack of clarity in the development process?
Common wrong responses
Faced with a stalling pipeline, organizations often mistakenly increase the volume of new offerings, hoping that quantity will compensate for a lack of portfolio discipline. This dilution of focus is frequently compounded by a reactive posture, where every disparate customer request is elevated to the level of strategy. Such responses ignore the underlying structural weaknesses, instead adding complexity to an already strained system and further eroding margins and delivery reliability.
How to approach it
Addressing these challenges requires evaluating the organization through three distinct strategic lenses. The Portfolio Matrix lens allows leadership to assess the balance of the entire pipeline, ensuring that resources are allocated to the most viable prospects rather than being spread too thin. A Product-Market Fit Review lens provides a rigorous assessment of whether an offering actually addresses a verifiable market need, preventing the launch of products that lack a clear destination. Finally, the Lifecycle Economics lens ensures that the financial implications of a product are understood from inception through decline, prioritizing long-term value over the mere completion of a launch schedule.
Diagnose this challenge
This brief draws on the structured challenge library in Cogliva, where the challenge can be diagnosed in the context of your organisation. To discuss it directly, see Advisory or Inquire.